» Articles » PMID: 32204476

Comparison of Structured Nutrition Therapy for Ramadan with Standard Care in Type 2 Diabetes Patients

Abstract

(1) Background: Structured nutrition therapy (NT) is essential for the management of type 2 diabetes (T2D), but the optimal delivery during Ramadan fasting remains unclear. The present study aimed to evaluate the effect of structured NT program versus standard care in patients with T2D during Ramadan. (2) Methods: The present study was an 8-week, parallel, non-randomized study with patients' preference design involving 64 patients with T2D. The participants were asked to choose their preferred group, i.e., structured NT (Structured Ramadan NT, sRNT) or standard care (SC). The participants in the sRNT group received a Ramadan-focused nutrition plan, including a diabetes-specific formula throughout the study, whereas the patients in the SC group received standard nutrition care. Study outcomes included clinical outcomes and quality of life (QoL). Data was analyzed using two-way repeated-measures ANOVA and linear mixed-effects model. (3) Results: More than half of the participants ( = 38, 63%) chose sRNT as their preferred group. Both groups had comparable baseline characteristics. After 8-weeks of the respective intervention, participants in the sRNT group had lower levels of fasting plasma glucose (-0.9 ± 0.3 mmol/L vs. 0.2 ± 0.3 mmol/L, < 0.05), triglycerides (-0.21 ± 0.08 mmol/L vs. 0.20 ± 0.17 mmol/L, < 0.05), and self-monitoring glucose at pre-dawn (6.9 mmol/L vs. 7.8 mmol/L, < 0.05) and pre-bedtime (7.6 mmol/L vs. 8.6 mmol/L, < 0.05) than participants in the SC group. Although not different between groups, HbA1c levels decreased significantly in the sRNT (-0.72 ± 0.16%, < 0.001) but not in the SC group (-0.35 ± 0.24%, = 0.155). QoL and satisfaction scores improved significantly in sRNT group, but not in SC group. (4) Conclusions: The structured NT regimen for Ramadan is a feasible and beneficial program for T2D patients observing Ramadan fasting as it showed an improvement in clinical outcomes and QoL.

Citing Articles

Implications of the Glycemia Risk Index in Assessing Metabolic Control and its Correlation With Therapy-Related Quality of Life During-Ramadan Fasting in Adults With Type 2 Diabetes.

Al Hayek A, Al Zahrani W, Al Dawish M J Diabetes Sci Technol. 2025; :19322968251321860.

PMID: 40022432 PMC: 11871576. DOI: 10.1177/19322968251321860.


Evaluation of Glycemic Control in Patients With Diabetes by a Continuous Glucose Monitoring System During the Month of Ramadan.

Haraj N, Harouna Malam Brah N, Elaziz S, Chadli A Cureus. 2024; 16(10):e72710.

PMID: 39618608 PMC: 11606437. DOI: 10.7759/cureus.72710.


How quality of life is measured in studies of nutritional intervention: a systematic review.

Pemau R, Gonzalez-Palacios P, Kerr K Health Qual Life Outcomes. 2024; 22(1):9.

PMID: 38267976 PMC: 10809546. DOI: 10.1186/s12955-024-02229-y.


Ramadan-specific nutrition education improves cardio-metabolic health and inflammation-a prospective nutrition intervention study from Pakistan.

Gul R, Khan I, Alam I, Almajwal A, Hussain I, Sohail N Front Nutr. 2024; 10:1204883.

PMID: 38249603 PMC: 10798056. DOI: 10.3389/fnut.2023.1204883.


Ramadan fasting and weight change trajectories: Time-varying association of weight during and after Ramadan in low-income and refugee populations.

Zoughbie D, James Ng T, Thompson J, Watson K, Farraj R, Ding E PLOS Glob Public Health. 2023; 2(10):e0000371.

PMID: 36962504 PMC: 10021413. DOI: 10.1371/journal.pgph.0000371.


References
1.
Goldberg G, Black A, Jebb S, Cole T, Murgatroyd P, Coward W . Critical evaluation of energy intake data using fundamental principles of energy physiology: 1. Derivation of cut-off limits to identify under-recording. Eur J Clin Nutr. 1991; 45(12):569-81. View

2.
Hassanein M, Abdelgadir E, Bashier A, Rashid F, Al Saeed M, Khalifa A . The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetes. Diabetes Res Clin Pract. 2019; 150:288-295. DOI: 10.1016/j.diabres.2018.12.013. View

3.
Hirst J, Stevens R, Farmer A . Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication change. PLoS One. 2014; 9(3):e92458. PMC: 3965408. DOI: 10.1371/journal.pone.0092458. View

4.
Wadden T, West D, Delahanty L, Jakicic J, Rejeski J, Williamson D . The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring). 2006; 14(5):737-52. PMC: 2613279. DOI: 10.1038/oby.2006.84. View

5.
Hassanein M, Al-Arouj M, Hamdy O, Mohamad Wan Bebakar W, Jabbar A, Al-Madani A . Diabetes and Ramadan: Practical guidelines. Diabetes Res Clin Pract. 2017; 126:303-316. DOI: 10.1016/j.diabres.2017.03.003. View